OBULAPATHI UMMADISETTY

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Peripheral Cannabinoid Receptor Activation Attenuates Frostbite-Induced Chronic Pain via Modulation of TRP Channels, Neuroinflammation, and Autophagy.
  Free radical biology & medicine 2026 DOI: 10.1016/j.freeradbiomed.2026.02.059
  +Save
• Activation of peripheral cannabinoid receptors by CB13 attenuates burn injury-induced chronic pain through TRP channel modulation.
  British journal of pharmacology 2026 DOI: 10.1111/bph.70350
  +Save
• 3D Tetrametallic Dendrite-Based Non-Enzymatic Sensor Coupled with a Smartphone Interface for GSH Quantification in Biological Fluids and Ex Vivo Rat Models.
  ACS applied materials & interfaces 2025 DOI: 10.1021/acsami.5c10664
  +Save
• Dermorphin [D-Arg2, Lys4] (1-4) Amide Attenuates Burn Pain by Inhibiting TRPV1/NR2B Mediated Neuroinflammatory Signalling.
  Molecular neurobiology 2025 DOI: 10.1007/s12035-025-05068-0
  +Save
• Dermorphin [D-Arg2, Lys4] (1-4) Amide Alleviates Frostbite-Induced Pain by Regulating TRP Channel-Mediated Microglial Activation and Neuroinflammation
  Molecular Neurobiology 2024 DOI: 10.1007/s12035-024-03949-4
  +Save
• Development and validation of clinically Mimicable model of frostbite injury-induced chronic pain.
  Cellular signalling 2024 DOI: 10.1016/j.cellsig.2023.111028
  +Save
• Peripheral mu-opioid receptor activation by dermorphin [D-Arg2, Lys4] (1–4) amide alleviates behavioral and neurobiological aberrations in rat model of chemotherapy-induced neuropathic pain
  Neurotherapeutics 2023 DOI: 10.1016/j.neurot.2023.10.012
  +Save
• Bergenin ameliorates chemotherapy-induced neuropathic pain in rats by modulating TRPA1/TRPV1/NR2B signalling
  International Immunopharmacology 2023 DOI: 10.1016/j.intimp.2023.111100
  +Save
• Loperamide, a peripheral Mu-Opioid receptor agonist, attenuates chemotherapy-induced neuropathic pain in rats.
  International immunopharmacology 2023 DOI: 10.1016/j.intimp.2023.110944
  +Save
• Unlocking the potential of TRPV1 based siRNA therapeutics for the treatment of chemotherapy-induced neuropathic pain
  Life Sciences 2022 DOI: 10.1016/j.lfs.2021.120187
  +Save